Amsacrine combined with etoposide and methylprednisolone is a feasible and safe component in first-line intensified treatment of pediatric patients with high-risk acute lymphoblastic leukemia in CoALL08-09 trial.
Pediatr Blood Cancer
; 69(12): e29997, 2022 12.
Article
in En
| MEDLINE
| ID: mdl-36129234
Full text:
1
Database:
MEDLINE
Main subject:
Hematopoietic Stem Cell Transplantation
/
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Type of study:
Clinical_trials
/
Etiology_studies
/
Risk_factors_studies
Limits:
Child
/
Humans
Language:
En
Year:
2022
Type:
Article